iconiifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Sun Pharma to announce Q3 financial performance on January 31

19 Jan 2022 , 12:36 PM

Sun Pharma

Sun Pharmaceutical Industries has scheduled January 31 as the date for announcing its financial performance for the quarter ending December 2021 (Q3FY22).

The Company will conduct an hour-long call at 06.30 pm IST on January 31, 2022, where senior management will discuss the Company’s performance and answer questions from participants.

On Wednesday, the company's stock was under pressure. At around 10.49 am, Sun Pharma was performing at Rs836.80 per piece down by 1.08%.

The stock has touched an intraday high and low of Rs846.15 per piece and Rs834.05 per piece respectively.

In the September 2021 quarter (Q2FY22), Sun Pharma reported a 12.54% yoy rise in total revenues on a consolidated basis at Rs9,626cr. The consolidated Profit after tax (PAT) was up by 12.92% yoy at Rs2,047cr as most of the operating cost items including the raw material costs remained stable during the quarter.

Related Tags

  • markets
  • sensex
  • Sun Pharma
  • Sun Pharma earnings
  • Sun Pharma news
  • Sun Pharma Q3 data
  • Sun Pharma Q3 financial performance
sidebar mobile

BLOGS AND PERSONAL FINANCE

Images
19 Mar 2024   |   10:37 AM
Images
18 Mar 2024   |   11:30 AM
Images
18 Mar 2024   |   10:42 AM
Images
18 Mar 2024   |   10:36 AM
Read More

Most Read News

19 Mar 2024   |   01:54 PM
19 Mar 2024   |   01:53 PM
19 Mar 2024   |   01:27 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.